New study: abatacept therapy offers promising results treating juvenile dermatomyositis

Researchers at UMC Utrecht are developing a predictive model to accurately predict disease progress in juvenile dermatomyositis. The Interferon Score aims to identify which children can safely reduce medication and which require intensified treatment.

A clinical trial found that abatacept significantly reduces the progression to rheumatoid arthritis in patients with palindromic rheumatism. Patients treated with abatacept experienced improved symptoms and reduced risk of developing arthritis, compared to those receiving hydroxychloroquine treatment.

A new murine model of dermatomyositis reveals the underlying immune system involvement in this highly progressive disease. The study identifies key components of the immune system responsible for disease development and suggests potential treatments targeting interleukin-6.

A Phase 2b clinical trial published in The Lancet found that abatacept reduces progression to rheumatoid arthritis and can also ease symptoms. After a year-long treatment, patients treated with abatacept showed significant reductions in disease onset and inflammation.

A new study found that floating macroalgal rafts in the Ningaloo Coast World Heritage Area provide habitat for a diverse array of juvenile oceanic fish. The rafts, formed by dislodged algae, attract large numbers of juvenile fish and other animals, serving as a potentially important transitional habitat for pre-settlement coastal fishes.

A new study finds that juvenile male dolphins with strong social bonds practice adult-like reproductive behaviors when playing together, and those who spend more time practicing will father more offspring as adults. The research provides rare evidence for a link between juvenile social play and reproductive success in a wild animal.